This document is an excerpt from the EUR-Lex website
Document 62019TB0792
Case T-792/19: Order of the General Court of 4 December 2020 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA) (EU trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)
Case T-792/19: Order of the General Court of 4 December 2020 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA) (EU trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)
Case T-792/19: Order of the General Court of 4 December 2020 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA) (EU trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)
OJ C 35, 1.2.2021, p. 50–51
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
1.2.2021 |
EN |
Official Journal of the European Union |
C 35/50 |
Order of the General Court of 4 December 2020 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
(Case T-792/19) (1)
(EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)
(2021/C 35/66)
Language of the case: German
Parties
Applicant: Agepha Pharma s.r.o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)
Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Apogepha Arzneimittel GmbH (Dresden, Germany) (represented by: A. Marx and R. Kaase, lawyers)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 26 August 2019 (Case R 386/2019-2), relating to opposition proceedings between Apogepha Arzneimittel GmbH and Agepha Pharma s.r.o.
Operative part of the order
|
1. |
There is no longer any need to adjudicate on the action. |
|
2. |
Agepha Pharma s.r.o and Apogepha Arzneimittel GmbH shall bear their own costs and shall each pay half of the costs incurred by the European Union Intellectual Property Office (EUIPO). |